<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26020393</article-id>
      <article-id pub-id-type="pmc">4616402</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000000861</article-id>
      <article-id pub-id-type="art-access-id">00861</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>4900</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Disseminated <italic>Mycobacterium abscessus</italic> Infection Following Septic Arthritis</article-title>
        <subtitle>A Case Report and Review of the Literature</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fukui</surname>
            <given-names>Shoichi</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sekiya</surname>
            <given-names>Noritaka</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Takizawa</surname>
            <given-names>Yasunobu</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morioka</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kato</surname>
            <given-names>Hirofumi</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aono</surname>
            <given-names>Akio</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chikamatsu</surname>
            <given-names>Kinuyo</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mitarai</surname>
            <given-names>Satoshi</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kobayashi</surname>
            <given-names>Satomi</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kamei</surname>
            <given-names>Satoshi</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Setoguchi</surname>
            <given-names>Keigo</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Yong.</surname>
            <given-names>Tuck Yean</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>From the Department of Rheumatology (SF, YT, S Kobayashi, S Kamei, KS); Clinical Laboratory (NS, HM, HK), Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo; and Department of Mycobacterium Reference and Research (AA, KC, SM), The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, <country>Japan</country>.</aff>
      <author-notes>
        <corresp>Correspondence: Shoichi Fukui, Department of Rheumatology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan (e-mail: <email>fukui-ngs@umin.ac.jp</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <volume>94</volume>
      <issue>21</issue>
      <elocation-id>e861</elocation-id>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>12</month>
          <year>2014</year>
        </date>
        <date date-type="received">
          <day>8</day>
          <month>4</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>4</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2015 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-94-e861.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p><italic>Mycobacterium abscessus</italic> is a rapidly growing mycobacterium found mainly in patients with respiratory or cutaneous infections, but it rarely causes disseminated infections. Little is known about the clinical characteristics, treatment, and prognosis of disseminated <italic>M abscessus</italic> infection.</p>
        <p>A 75-year-old Japanese woman who had been treated for 17 years with a corticosteroid for antisynthetase syndrome with antithreonyl-tRNA synthetase antibody developed swelling of her right elbow. X-ray of her right elbow joint showed osteolysis, and magnetic resonance imaging revealed fluid in her right elbow joint. <italic>M abscessus</italic> grew in joint fluid and blood cultures. She was diagnosed with a disseminated <italic>M abscessus</italic> infection following septic arthritis. Antimicrobial treatment by clarithromycin, amikacin, and imipenem/cilastatin combined with surgical debridement was administered. Although blood and joint fluid cultures became negative 1 week later, the patient died at 6 weeks from starting antimicrobial treatment.</p>
        <p>We reviewed 34 cases of disseminated <italic>M abscessus</italic> infections from the literature. Most of the patients had immunosuppressive backgrounds such as transplantation, use of immunosuppressive agents, hematological malignancy, and end stage renal disease. The duration from onset of symptoms to diagnosis was over 3 months in half of the cases. All fatal cases had positive blood cultures or use of immunosuppressive agents.</p>
        <p>Clinicians should bear in mind that mycobacterial infections including <italic>M abscessus</italic> are one of the differential diagnoses in patients with subacute arthritis and soft tissue infections.</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p><italic>Mycobacterium abscessus</italic> is a rapidly growing mycobacterium that exists ubiquitously in the environment, for example, in soil, dust, and water.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> A distinction between <italic>M abscessus</italic> and <italic>M chelonae</italic> became apparent only after 1992 with the advent of the polymerase chain reaction method.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> The clinical manifestations of <italic>M abscessus</italic>, which caused a gluteal abscess in a woman with osteoarthritis, were first described in 1953.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> The most common types of <italic>M abscessus</italic> infections are respiratory tract infections<sup><xref rid="R4" ref-type="bibr">4</xref></sup> and localized skin and soft tissue infections.<sup><xref rid="R5" ref-type="bibr">5</xref></sup> Disseminated <italic>M abscessus</italic> infection is a rare clinical presentation, and little is known about its clinical characteristics, treatment, and prognosis. Here we report a case of disseminated <italic>M abscessus</italic> infection following septic arthritis, and we provide a review of the literature.</p>
    </sec>
    <sec>
      <title>CASE PRESENTATION</title>
      <p>A 75-year-old Japanese woman was admitted to our hospital complaining of swelling of the right elbow and the wrist joint for a month. She had no history of orthopedic surgery, joint trauma, or intraarticular injections in those joints. She had a 17-year history of dermatomyositis after being diagnosed at 58 years of age, along with interstitial lung disease (ILD), pulmonary hypertension, chronic kidney disease, and Raynaud phenomenon. She had pulmonary tuberculosis at the age of 33, resulting in old inflammatory changes and volume loss in the left lung. Later, her dermatomyositis proved to be antisynthetase syndrome with antithreonyl-tRNA synthetase antibody. Antisynthetase syndrome is characterized by the existence of antibodies to aminoacyl-transfer ribonucleic acid synthetase enzymes, myositis, ILD, arthropathy, fever, Raynaud phenomenon, and mechanic's hands.</p>
      <p>The patient had remained on corticosteroids for 17 years; at least 3 times she had received high-dose corticosteroid therapy, that is, 45&#x2013;60&#x200A;mg prednisolone (PSL) per day continued for 4 weeks and tapered, with or without pulsed methylprednisolone (P-MPSL). As for other immunosuppressants, methotrexate was only temporarily used 10 years before this event; they were never used after that time. Four years before her present admission, she experienced the last exacerbation of antisynthetase syndrome-associated ILD that required the high-dose PSL therapy and P-MPSL. Despite the therapy, her respiratory function worsened due to the progression of fibrosis, and she had to receive home oxygen therapy. The PSL was tapered gradually to 10&#x200A;mg per day over the next 3 years. She was on 9.5&#x200A;mg PSL per day at the time of admission. On physical examination, she was afebrile, and all other vital signs were within normal limits. Her right elbow, forearm, and wrist joint were swollen with tenderness. Erythema and warmth were noted on her right arm. No skin eruptions or nodules were found. The cardiopulmonary and abdominal findings were normal.</p>
      <p>Laboratory examinations showed that white blood cell count was 9000/&#x3BC;L (normal range 3300&#x2013;7600/&#x3BC;L, neutrophils 77%, lymphocytes 20%, monocytes 3%, and eosinophils 0%). Elevated serum levels of C-reactive protein (2.6&#x200A;mg/dL, normal range &lt;0.3&#x200A;mg/dL) and creatinine (1.2&#x200A;mg/dL, normal range 0.5&#x2013;0.8&#x200A;mg/dL, the estimated glomerular filtrating ratio was 34.0&#x200A;mL/min) were shown. No other abnormalities were detected on laboratory testing. X-ray of her right elbow joint showed osteolysis and pathological fracture of the right olecranon (Figure <xref ref-type="fig" rid="F1">1</xref>). Magnetic resonance imaging revealed fluid in her right elbow joint and forearm (Figure <xref ref-type="fig" rid="F2">2</xref>). In addition, there were high-intensity lesions in the right olecranon, which suggested an osteomyelitis. <italic>M abscessus</italic>, identified by <italic>hps65</italic> gene sequencing (100% homology), grew in blood and joint fluid cultures (BacT/ALERT system; Biom&#xE9;rieux, Marcy-l&#x2019;&#xC9; toile, France).</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>X-ray of the patient's right elbow joint. Osteolysis is seen (arrow).</p>
        </caption>
        <graphic xlink:href="medi-94-e861-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Magnetic resonance imaging shows fluid collection in the right elbow joint and forearm (arrows).</p>
        </caption>
        <graphic xlink:href="medi-94-e861-g002"/>
      </fig>
      <p>Breakpoint susceptibility testing was performed using the broth microdilution method with 10 drugs based on the recommendations of the Clinical and Laboratory Standards Institute M24-A2<sup><xref rid="R6" ref-type="bibr">6</xref></sup> (Table <xref ref-type="table" rid="T1">1</xref>). Sputum cultures were negative for mycobacteria. A surgical debridement of the right elbow joint, forearm, and wrist joint was performed. The extra fluid in the patient's right elbow joint and forearm was completely removed. We initiated a vancomycin treatment for the patient, empirically. Based on the culture reporting, we switched the antimicrobial treatment to clarithromycin, amikacin, and imipenem/cilastatin. This combination therapy was continued for 6 weeks. The daily PSL was maintained to prevent adrenal insufficiency.</p>
      <table-wrap id="T1" position="float">
        <label>TABLE 1</label>
        <caption>
          <p>Minimum Inhibitory Concentrations Using the Broth Microdilution Method</p>
        </caption>
        <graphic xlink:href="medi-94-e861-g003"/>
      </table-wrap>
      <p>The subsequent blood and joint fluid cultures became negative 1 week later. We placed a peripherally inserted central catheter in the right jugular vein for long-term intravenous antimicrobial therapy.</p>
      <p>One month after the initiation of antimicrobials, the patient became febrile, and blood cultures turned positive for yeast-like fungi, which were identified as <italic>Candida albicans</italic>. The patient also had candida endophthalmitis. We added micafungin and later changed the micafungin to fluconazole based on the blood culture results. Although the subsequent blood cultures became negative for <italic>C albicans</italic>, a pleural effusion was increased with paroxysmal atrial fibrillation. The pleural fluid culture was negative. Two weeks later, the patient died due to respiratory failure possibly related to the disseminated candidiasis. An autopsy was not performed, per her family's request.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Disseminated nontuberculosis mycobacterial infections in non-HIV-infected patients are considered uncommon.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> Although some cases were reported in the recent literature, there have been few large epidemiological or clinical studies of disseminated mycobacterial infections. Disseminated <italic>M abscessus</italic> infections such as that seen in our patient are extremely rare, and we therefore reviewed the past case reports and case series of disseminated <italic>M abscessus</italic> infections in non-HIV-infected patients by conducting a PubMed (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed">http://www.ncbi.nlm.nih.gov/pubmed</ext-link>) search. Our search of reports from 1953 to 2014 used the search terms &#x201C;dissemination,&#x201D; &#x201C;disseminated infection,&#x201D; &#x201C;<italic>M abscessus</italic>,&#x201D; and &#x201C;non-tuberculosis mycobacteria.&#x201D;</p>
      <p>Disseminated <italic>M abscessus</italic> infections are defined by at least one of the following characteristics: involvement of &gt;1 organ, involvement of &gt;2 groups of lymph nodes, or positive blood culture.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> We included cases that met these criteria. Table <xref ref-type="table" rid="T2">2</xref>&#xA0; shows the data obtained regarding the background, diagnostic process, and treatment for 34 patients.<sup><xref rid="R8" ref-type="bibr">8</xref>&#x2013;<xref rid="R27" ref-type="bibr">27</xref></sup></p>
      <table-wrap id="T2" position="float">
        <label>TABLE 2</label>
        <caption>
          <p>Demographic Data and Medical History of Disseminated <italic>Mycobacterium abscessus</italic> Infection Cases</p>
        </caption>
        <graphic xlink:href="medi-94-e861-g004"/>
      </table-wrap>
      <table-wrap id="T3" position="float">
        <label>TABLE 2 (Continued)</label>
        <caption>
          <p>Demographic Data and Medical History of Disseminated <italic>Mycobacterium abscessus</italic> Infection Cases</p>
        </caption>
        <graphic xlink:href="medi-94-e861-g005"/>
      </table-wrap>
      <p>Previous reports suggested that immunosuppressive backgrounds were risk factors, such as organ transplants<sup><xref rid="R9" ref-type="bibr">9</xref>&#x2013;<xref rid="R13" ref-type="bibr">13</xref></sup> and corticosteroid therapy for autoimmune diseases.<sup><xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup> Most of the patients listed in Table <xref ref-type="table" rid="T2">2</xref>&#xA0; had immunosuppressive backgrounds, 8 patients had a history of organ transplant, and 3 other patients received corticosteroid treatment. All these patients were in actively immunocompromised status, which meant the status with concurrent use of prednisolone or other immunosuppressive agents for visceral transplantations or autoimmune diseases at the time of infection. Our patient was treated with corticosteroid therapy for a long time, which could have been a risk for dissemination.</p>
      <p>We also examined the patients&#x2019; history of tuberculosis.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> Four patients had a history of tuberculosis (Table <xref ref-type="table" rid="T2">2</xref>&#xA0;). Specific cytokines, such as interleukin-12 and interferon gamma, are known to play an important role in the prevention of mycobacterial infections.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> However, it is not clear whether there was some potential vulnerability to mycobacterial infections in our patient.</p>
      <p>She was diagnosed with disseminated infection 1 month after developing arthritis. Because mycobacterial infections typically show subacute disease progression, a delayed diagnosis may affect the progression to disseminated infections in some cases. Table <xref ref-type="table" rid="T2">2</xref>&#xA0; shows that the duration before diagnosis was &gt;3 months in 48% of the cases (10/21, only assessed cases).</p>
      <p>With regard to treatment, clarithromycin or azithromycin combined with parenteral medications (amikacin, cefoxitin, or imipenem) for serious infections is recommended.<sup><xref rid="R29" ref-type="bibr">29</xref></sup> Of the parenteral antibiotics, amikacin is an important effective agent against <italic>M abscessus</italic>.<sup><xref rid="R30" ref-type="bibr">30</xref></sup> Although clarithromycin is the cornerstone of therapy for <italic>M abscessus</italic>,<sup><xref rid="R31" ref-type="bibr">31</xref></sup> clarithromycin-resistant <italic>M abscessus</italic> was reported, which was associated with <italic>erm</italic>(41) gene and <italic>rrl</italic> mutation.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> Because of the varying in vitro drug susceptibilities to some drugs, the antibiotic susceptibility testing of all clinically significant isolates is recommended.<sup><xref rid="R29" ref-type="bibr">29</xref></sup> The prevalence of susceptibility of <italic>M abscessus</italic> to amikacin, clarithromycin, cefoxitin, and imipenem was reported to be 95%, 92.5%, 32.5%, and 12.5%, respectively.<sup><xref rid="R33" ref-type="bibr">33</xref></sup></p>
      <p>Although our patient was treated with clarithromycin, amikacin, and imipenem, her strain was susceptible only to amikacin and resistant to other antibiotics including clarithromycin and imipenem (Table <xref ref-type="table" rid="T1">1</xref>). The subsequent cultures rapidly turned out to be negative, in contrast to the susceptibility. Multiple contributing factors could have led to respiratory failure and death, but the impact of <italic>M abscessus</italic> infection on the clinical course was unclear. Because a pleural fluid culture was negative for <italic>M abscessus</italic>, the pleural fluid may have been caused by either hypoalbuminemia caused by a continuous inflammation or heart failure. In addition, antisynthetase-syndrome-associated ILD or adverse effects of the antimicrobial combination therapy may have affected her respiratory failure.</p>
      <p>The prognostic factors of disseminated <italic>M abscessus</italic> infections have not been well evaluated. As shown in Table <xref ref-type="table" rid="T2">2</xref>&#xA0;, 48% of the cases (15/31, only assessed cases) were fatal. Table <xref ref-type="table" rid="T3">3</xref> shows the clinical characteristics of the patients who died and those who survived. Although a statistical analysis was not conducted due to limitations of available data and selection bias, late diagnosis seems unrelated to poor prognosis.</p>
      <table-wrap id="T4" position="float">
        <label>Table 3</label>
        <caption>
          <p>Comparison of Patients Who Died and Patients Who Survived</p>
        </caption>
        <graphic xlink:href="medi-94-e861-g006"/>
      </table-wrap>
      <p>In contrast, cases with immunosuppressive agents and positive blood cultures are likely to be fatal. All fatal cases had received immunosuppressive agents or positive blood cultures (Table <xref ref-type="table" rid="T3">3</xref>). These observations prompted us to hypothesize that bacteremia and immunosuppressive agents rather than late diagnosis might be associated with poor prognosis in disseminated <italic>M abscessus</italic> infections. The characteristics of our patient are consistent with this hypothesis; an immunocompromised host associated with prednisolone for antisynthetase syndrome with antithreonyl-tRNA synthetase antibody and positive blood cultures. Further evaluations are needed to elucidate the prognostic factors for individuals with an <italic>M abscessus</italic> infection.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>CONCLUSION</title>
      <p>We described the case of a patient with a disseminated <italic>M abscessus</italic> infection following septic arthritis and provided a literature review. Disseminated <italic>M abscessus</italic> infections lead to poor prognosis, especially in patients with bacteremia and immunosuppressive agents rather than late diagnosis. Adequate clinical intervention to improve the outcome is unclear, but we need to be aware that mycobacterial infections including <italic>M abscessus</italic> should be included in clinicians&#x2019; differential diagnoses among patients with subacute arthritis and soft tissue infections.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: ILD = interstitial lung disease, P-MPSL = pulsed methylprednisolone, PSL = prednisolone.</p>
      </fn>
      <fn fn-type="con">
        <p>SF and NS drafted the manuscript and made a substantial contribution to the concept and design. SF, NS, HM, HK, S Kobayashi, S Kamei, YT, and KS treated the patient and collected the primary data. AA, KS, and SM conducted the species identification and antimicrobial susceptibility testing of <italic>Mycobacterium abscessus</italic>. HM, HK, SK, SK, YT, and KS critically revised the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
      <fn fn-type="other">
        <p>Written informed consent was obtained from the patient's husband for the publication of this case report.</p>
      </fn>
      <fn fn-type="conflict">
        <p>The authors have no funding and conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab><article-title>Infection with <italic>Mycobacterium abscessus</italic> associated with intramuscular injection of adrenal cortex extract&#x2014;Colorado and Wyoming, 1995&#x2013;1996</article-title>. <source><italic>JAMA</italic></source>
<year>1996</year>; <volume>276</volume>:<fpage>1130</fpage>.<pub-id pub-id-type="pmid">8827955</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakrus</surname><given-names>MA</given-names></name><name><surname>Hernandez</surname><given-names>SM</given-names></name><name><surname>Floyd</surname><given-names>MM</given-names></name><etal/></person-group>
<article-title>Comparison of methods for identification of <italic>Mycobacterium abscessus</italic> and <italic>M. chelonae</italic> isolates</article-title>. <source><italic>J Clin Microbiol</italic></source>
<year>2001</year>; <volume>39</volume>:<fpage>4103</fpage>&#x2013;<lpage>4110</lpage>.<pub-id pub-id-type="pmid">11682537</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>M</given-names></name><name><surname>Frerichs</surname><given-names>JB</given-names></name></person-group>
<article-title>An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, <italic>Mycobacterium abscessus</italic>, n. sp</article-title>. <source><italic>J Invest Dermatol</italic></source>
<year>1953</year>; <volume>20</volume>:<fpage>133</fpage>&#x2013;<lpage>169</lpage>.<pub-id pub-id-type="pmid">13035193</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>DE</given-names></name><name><surname>Girard</surname><given-names>WM</given-names></name><name><surname>Wallace</surname><given-names>RJ</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients</article-title>. <source><italic>Am Rev Respir Dis</italic></source>
<year>1993</year>; <volume>147</volume>:<fpage>1271</fpage>&#x2013;<lpage>1278</lpage>.<pub-id pub-id-type="pmid">8484642</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuya</surname><given-names>EY</given-names></name><name><surname>Paez</surname><given-names>A</given-names></name><name><surname>Srinivasan</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Outbreak of <italic>Mycobacterium abscessus</italic> wound infections among &#x201C;lipotourists&#x201D; from the United States who underwent abdominoplasty in the Dominican Republic</article-title>. <source><italic>Clin Infect Dis</italic></source>
<year>2008</year>; <volume>46</volume>:<fpage>1181</fpage>&#x2013;<lpage>1188</lpage>.<pub-id pub-id-type="pmid">18444853</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="book"><source>Clinical and Laboratory Standards Institute: Susceptibility testing of Mycobacteria, Nocardiae and other aerobic Actinomycetes: Approved standard&#x2013; second edition. CLSI document M24-A2. 2011</source>. <publisher-loc>Wayne, Pennsylvania</publisher-loc>: <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>; <year>2011</year>.</mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chetchotisakd</surname><given-names>P</given-names></name><name><surname>Kiertiburanakul</surname><given-names>S</given-names></name><name><surname>Mootsikapun</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand</article-title>. <source><italic>Clin Infect Dis</italic></source>
<year>2007</year>; <volume>45</volume>:<fpage>421</fpage>&#x2013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">17638188</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chetchotisakd</surname><given-names>P</given-names></name><name><surname>Mootsikapun</surname><given-names>P</given-names></name><name><surname>Anunnatsiri</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity</article-title>. <source><italic>Clin Infect Dis</italic></source>
<year>2000</year>; <volume>30</volume>:<fpage>29</fpage>&#x2013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">10619729</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanguinetti</surname><given-names>M</given-names></name><name><surname>Ardito</surname><given-names>F</given-names></name><name><surname>Fiscarelli</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Fatal pulmonary infection due to multidrug-resistant <italic>Mycobacterium abscessus</italic> in a patient with cystic fibrosis</article-title>. <source><italic>J Clin Microbiol</italic></source>
<year>2001</year>; <volume>39</volume>:<fpage>816</fpage>&#x2013;<lpage>819</lpage>.<pub-id pub-id-type="pmid">11158161</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Gil</surname><given-names>A</given-names></name><name><surname>Santos</surname><given-names>M</given-names></name></person-group>
<article-title><italic>Mycobacterium abscessus</italic> infection in transplant recipients</article-title>. <source><italic>Transplant Proc</italic></source>
<year>2010</year>; <volume>42</volume>:<fpage>3058</fpage>&#x2013;<lpage>3060</lpage>.<pub-id pub-id-type="pmid">20970610</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoll</surname><given-names>BM</given-names></name><name><surname>Kappagoda</surname><given-names>S</given-names></name><name><surname>Gill</surname><given-names>RR</given-names></name><etal/></person-group>
<article-title>Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study</article-title>. <source><italic>Transpl Infect Dis</italic></source>
<year>2012</year>; <volume>14</volume>:<fpage>452</fpage>&#x2013;<lpage>460</lpage>.<pub-id pub-id-type="pmid">22676720</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrison</surname><given-names>AP</given-names></name><name><surname>Morris</surname><given-names>MI</given-names></name><name><surname>Doblecki Lewis</surname><given-names>S</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium abscessus</italic> infection in solid organ transplant recipients: report of three cases and review of the literature</article-title>. <source><italic>Transpl Infect Dis</italic></source>
<year>2009</year>; <volume>11</volume>:<fpage>541</fpage>&#x2013;<lpage>548</lpage>.<pub-id pub-id-type="pmid">19671119</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>JL</given-names></name><name><surname>Palmer</surname><given-names>SM</given-names></name></person-group>
<article-title><italic>Mycobacterium abscessus</italic> chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient</article-title>. <source><italic>J Heart Lung Transplant</italic></source>
<year>2006</year>; <volume>25</volume>:<fpage>985</fpage>&#x2013;<lpage>988</lpage>.<pub-id pub-id-type="pmid">16890122</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spellberg</surname><given-names>B</given-names></name><name><surname>Yoo</surname><given-names>T</given-names></name><name><surname>Bayer</surname><given-names>AS</given-names></name></person-group>
<article-title>Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6</article-title>. <source><italic>J Antimicrob Chemother</italic></source>
<year>2004</year>; <volume>54</volume>:<fpage>832</fpage>&#x2013;<lpage>835</lpage>.<pub-id pub-id-type="pmid">15317746</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>YM</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>PC</given-names></name><etal/></person-group>
<article-title>Disseminated <italic>Mycobacterium abscessus</italic> infection and showerheads, Taiwan</article-title>. <source><italic>Emerg Infect Dis</italic></source>
<year>2011</year>; <volume>17</volume>:<fpage>2077</fpage>&#x2013;<lpage>2078</lpage>.<pub-id pub-id-type="pmid">22099106</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ingen</surname><given-names>J</given-names></name><name><surname>de Zwaan</surname><given-names>R</given-names></name><name><surname>Dekhuijzen</surname><given-names>RP</given-names></name><etal/></person-group>
<article-title>Clinical relevance of <italic>Mycobacterium chelonae</italic>-<italic>abscessus</italic> group isolation in 95 patients</article-title>. <source><italic>J Infect</italic></source>
<year>2009</year>; <volume>59</volume>:<fpage>324</fpage>&#x2013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">19732795</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name><name><surname>To</surname><given-names>KK</given-names></name><name><surname>Teng</surname><given-names>JL</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium abscessus</italic> bacteremia after receipt of intravenous infusate of cytokine-induced killer cell therapy for body beautification and health boosting</article-title>. <source><italic>Clin Infect Dis</italic></source>
<year>2013</year>; <volume>57</volume>:<fpage>981</fpage>&#x2013;<lpage>991</lpage>.<pub-id pub-id-type="pmid">23825355</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MR</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>YC</given-names></name><etal/></person-group>
<article-title>CNS infections caused by <italic>Mycobacterium abscessus</italic> complex: clinical features and antimicrobial susceptibilities of isolates</article-title>. <source><italic>J Antimicrob Chemother</italic></source>
<year>2012</year>; <volume>67</volume>:<fpage>222</fpage>&#x2013;<lpage>225</lpage>.<pub-id pub-id-type="pmid">21980068</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liebeskind</surname><given-names>DS</given-names></name><name><surname>Ostrzega</surname><given-names>N</given-names></name><name><surname>Wasterlain</surname><given-names>CG</given-names></name><etal/></person-group>
<article-title>Neurologic manifestations of disseminated infection with <italic>Mycobacterium abscessus</italic></article-title>. <source><italic>Neurology</italic></source>
<year>2001</year>; <volume>56</volume>:<fpage>810</fpage>&#x2013;<lpage>813</lpage>.<pub-id pub-id-type="pmid">11274327</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>RJ</given-names><suffix>Jr</suffix></name><name><surname>Swenson</surname><given-names>JM</given-names></name><name><surname>Silcox</surname><given-names>VA</given-names></name><etal/></person-group>
<article-title>Spectrum of disease due to rapidly growing mycobacteria</article-title>. <source><italic>Rev Infect Dis</italic></source>
<year>1983</year>; <volume>5</volume>:<fpage>657</fpage>&#x2013;<lpage>679</lpage>.<pub-id pub-id-type="pmid">6353528</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>SH</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Tsai</surname><given-names>TY</given-names></name><etal/></person-group>
<article-title>Catheter-related <italic>Mycobacterium abscessus</italic> bacteremia manifested with skin nodules, pneumonia, and mediastinal lymphadenopathy</article-title>. <source><italic>Kaohsiung J Med Sci</italic></source>
<year>2013</year>; <volume>29</volume>:<fpage>50</fpage>&#x2013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">23257257</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenzweig</surname><given-names>SD</given-names></name><name><surname>Dorman</surname><given-names>SE</given-names></name><name><surname>Uzel</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>A novel mutation in IFN-gamma receptor 2 with dominant negative activity: biological consequences of homozygous and heterozygous states</article-title>. <source><italic>J Immunol</italic></source>
<year>2004</year>; <volume>173</volume>:<fpage>4000</fpage>&#x2013;<lpage>4008</lpage>.<pub-id pub-id-type="pmid">15356149</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>CC</given-names></name><name><surname>Chao</surname><given-names>CM</given-names></name><name><surname>Gau</surname><given-names>SJ</given-names></name><etal/></person-group>
<article-title>Thoracic empyema and bacteremia due to <italic>Mycobacterium abscessus</italic> in a patient with liver cirrhosis</article-title>. <source><italic>J Microbiol Immunol Infect</italic></source>
<year>2013</year>; <volume>46</volume>:<fpage>482</fpage>&#x2013;<lpage>484</lpage>.<pub-id pub-id-type="pmid">23831159</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bax</surname><given-names>HI</given-names></name><name><surname>Freeman</surname><given-names>AF</given-names></name><name><surname>Anderson</surname><given-names>VL</given-names></name><etal/></person-group>
<article-title>B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency</article-title>. <source><italic>J Clin Immunol</italic></source>
<year>2013</year>; <volume>33</volume>:<fpage>1062</fpage>&#x2013;<lpage>1066</lpage>.<pub-id pub-id-type="pmid">23800860</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asai</surname><given-names>Y</given-names></name><name><surname>Ouchi</surname><given-names>H</given-names></name><name><surname>Ohosima</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>A case of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome, complicated with disseminated <italic>M. abscessus</italic> infection</article-title>. <source><italic>Nihon Kokyuki Gakkai Zasshi</italic></source>
<year>2009</year>; <volume>47</volume>:<fpage>1120</fpage>&#x2013;<lpage>1125</lpage>.<pub-id pub-id-type="pmid">20058690</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sungkanuparph</surname><given-names>S</given-names></name><name><surname>Sathapatayavongs</surname><given-names>B</given-names></name><name><surname>Pracharktam</surname><given-names>R</given-names></name></person-group>
<article-title>Infections with rapidly growing mycobacteria: report of 20 cases</article-title>. <source><italic>Int J Infect Dis</italic></source>
<year>2003</year>; <volume>7</volume>:<fpage>198</fpage>&#x2013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">14563223</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phowthongkum</surname><given-names>P</given-names></name><name><surname>Prasanthai</surname><given-names>V</given-names></name><name><surname>Udomsantisook</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand</article-title>. <source><italic>J Med Assoc Thai</italic></source>
<year>2005</year>; <volume>88</volume>:<fpage>1153</fpage>&#x2013;<lpage>1162</lpage>.<pub-id pub-id-type="pmid">16404850</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrado</surname><given-names>E</given-names></name><name><surname>Cooper</surname><given-names>AM</given-names></name></person-group>
<article-title>Cytokines in the balance of protection and pathology during mycobacterial infections</article-title>. <source><italic>Adv Exp Med Biol</italic></source>
<year>2013</year>; <volume>783</volume>:<fpage>121</fpage>&#x2013;<lpage>140</lpage>.<pub-id pub-id-type="pmid">23468107</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>DE</given-names></name><name><surname>Aksamit</surname><given-names>T</given-names></name><name><surname>Brown-Elliott</surname><given-names>BA</given-names></name><etal/></person-group>
<article-title>An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases</article-title>. <source><italic>Am J Respir Crit Care Med</italic></source>
<year>2007</year>; <volume>175</volume>:<fpage>367</fpage>&#x2013;<lpage>416</lpage>.<pub-id pub-id-type="pmid">17277290</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown-Elliott</surname><given-names>BA</given-names></name><name><surname>Wallace</surname><given-names>RJ</given-names><suffix>Jr</suffix></name></person-group>
<article-title>Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria</article-title>. <source><italic>Clin Microbiol Rev</italic></source>
<year>2002</year>; <volume>15</volume>:<fpage>716</fpage>&#x2013;<lpage>746</lpage>.<pub-id pub-id-type="pmid">12364376</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>BA</given-names></name><name><surname>Wallace</surname><given-names>RJ</given-names><suffix>Jr</suffix></name><name><surname>Onyi</surname><given-names>GO</given-names></name><etal/></person-group>
<article-title>Activities of four macrolides, including clarithromycin, against <italic>Mycobacterium fortuitum</italic>, <italic>Mycobacterium chelonae</italic>, and <italic>M. chelonae</italic>-like organisms</article-title>. <source><italic>Antimicrob Agents Chemother</italic></source>
<year>1992</year>; <volume>36</volume>:<fpage>180</fpage>&#x2013;<lpage>184</lpage>.<pub-id pub-id-type="pmid">1317144</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bastian</surname><given-names>S</given-names></name><name><surname>Veziris</surname><given-names>N</given-names></name><name><surname>Roux</surname><given-names>AL</given-names></name><etal/></person-group>
<article-title>Assessment of clarithromycin susceptibility in strains belonging to the <italic>Mycobacterium abscessus</italic> group by erm(41) and rrl sequencing</article-title>. <source><italic>Antimicrob Agents Chemother</italic></source>
<year>2011</year>; <volume>55</volume>:<fpage>775</fpage>&#x2013;<lpage>781</lpage>.<pub-id pub-id-type="pmid">21135185</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YC</given-names></name><name><surname>Liu</surname><given-names>MF</given-names></name><name><surname>Shen</surname><given-names>GH</given-names></name><etal/></person-group>
<article-title>Clinical outcome of <italic>Mycobacterium abscessus</italic> infection and antimicrobial susceptibility testing</article-title>. <source><italic>J Microbiol Immunol Infect</italic></source>
<year>2010</year>; <volume>43</volume>:<fpage>401</fpage>&#x2013;<lpage>406</lpage>.<pub-id pub-id-type="pmid">21075707</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
